To switch (statins) or not to switch? That is the question

被引：7

作者：

Athyros, Vasilios G. ^{[3
]}

Tziomalos, Konstantinos ^{[2
]}

Karagiannis, Asterios ^{[3
]}

Mikhailidis, Dimitri P. ^{[1
]}

机构：

[1] UCL, Univ Coll London Med Sch, Dept Clin Biochem, London NW3 2QG, England

[2] Aristotle Univ Thessaloniki, Sch Med, AHEPA Univ Hosp, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, Sch Med, Hippokrat Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2010年 / 11卷 / 18期

关键词：

cardiovascular disease; cholesterol; cost; generic; goals; statin; switching; CORONARY-ARTERY-DISEASE; LIPID-LOWERING THERAPY; HEART-DISEASE; SIMVASTATIN; ATORVASTATIN; OUTCOMES; METAANALYSIS; TRIALS; ROSUVASTATIN; REVERSAL;

D O I：

10.1517/14656566.2010.522991

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cost is an important consideration when deciding which drugs to prescribe. The problem is becoming more evident because effective, well-tolerated and evidence-based generic drugs are now widely available. More specifically, switching to a cheaper statin formulation might result in less effective treatment in terms of event reduction or achievement of lipid goal. Better patient adherence to treatment is also not always achieved by switching to generics. This editorial considers this debate.

引用

页码：2943 / 2946

页数：4

共 50 条

[1] LDL cholesterol levels after switch from atorvastatin to rosuvastatin
Lewis, Sandra J.
Olufade, Temitope
Anzalone, Deborah A.
Malangone-Monaco, Elisabetta
Evans, Kristin A.
Johnston, Stephen
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1717 - 1723
[2] The Immunomodulatory Effects of Statins on Macrophages
Sheridan, Alanah
Wheeler-Jones, Caroline P. D.
Gage, Matthew C.
IMMUNO, 2022, 2 (02): : 317 - 343
[3] Drug utilization studies and pharmacoeconomic analysis of statins used in prevention of coronary artery disease patients
Al Hamoudi, Alyazyah Mohamed Abdullah
Baig, Mirza R.
Jaber, Ammar Ali
REVISTA LATINOAMERICANA DE HIPERTENSION, 2024, 19 (01): : 25 - 31
[4] Statins in the elderly: an answered question?
Zoungas, Sophia
Curtis, Andrea
Tonkin, Andrew
McNeil, John
CURRENT OPINION IN CARDIOLOGY, 2014, 29 (04) : 372 - 380
[5] Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!
Ferrari, Filipe
Santos, Raul D.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (01) : 147 - 151
[6] Statins and Diabetes
Maki, Kevin C.
Dicklin, Mary R.
Baum, Seth J.
CARDIOLOGY CLINICS, 2015, 33 (02) : 233 - 243
[7] How to Switch to the Switch: Implementation of Biliopancreatic Diversion with Duodenal Switch into Practice
Halawani, Hamzeh M.
Antanavicius, Gintaras
Bonanni, Fernando
OBESITY SURGERY, 2017, 27 (09) : 2506 - 2509
[8] Statins and Elderly: From Clinical Trials to Daily Practice
Verdoia, Monica
Galasso, Gennaro
Filardi, Pasquale Perrone
De Luca, Giuseppe
CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (03) : 233 - 238
[9] Statins may be beneficial for patients with pulmonary hypertension secondary to lung diseases
Zhang, Ming-Zhou
Qian, De-Hui
Xu, Jian-Cheng
Yao, Wei
Fan, Ye
Wang, Chang-Zheng
JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2437 - 2446
[10] Diabetes Secondary to Treatment with Statins
Laakso, Markku
Kuusisto, Johanna
CURRENT DIABETES REPORTS, 2017, 17 (02)

← 1 2 3 4 5 →